Send mail to Author

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _      ___     _    _     _____               _____   
| \  / ||   / _ \\  | || | ||  |  ___||   ____     |  ___|| 
|  \/  ||  / //\ \\ | || | ||  | ||__    |    \\   | ||__   
| .  . || |  ___  ||| \\_/ ||  | ||__    | [] ||   | ||__   
|_|\/|_|| |_||  |_|| \____//   |_____||  |  __//   |_____|| 
`-`  `-`  `-`   `-`   `---`    `-----`   |_|`-`    `-----`  
                                         `-`
 


Back to frontdoor view

OPUS4 Logo